Clinical trial
Phase III Placebo-Controlled Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma Patients
NCT00201279 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Placebo-Controlled Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma Patients
- Lead sponsor
- National Health Research Institutes, Taiwan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 1999
- Completion date
- September 30, 2012
- Enrollment
- 342
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oral cavity, squamous cell carcinoma